GT200000222A - Forma de dosificacion de farmacos accionada por un hidrogel. - Google Patents

Forma de dosificacion de farmacos accionada por un hidrogel.

Info

Publication number
GT200000222A
GT200000222A GT200000222A GT200000222A GT200000222A GT 200000222 A GT200000222 A GT 200000222A GT 200000222 A GT200000222 A GT 200000222A GT 200000222 A GT200000222 A GT 200000222A GT 200000222 A GT200000222 A GT 200000222A
Authority
GT
Guatemala
Prior art keywords
dosage form
hydrogel
drugs
driven
pharmaco
Prior art date
Application number
GT200000222A
Other languages
English (en)
Inventor
Leah Elizabeth Appel
Ronal Arthur Beyerinck
Mark Brian Chidlaw
William John Curatolo
Dwayne Thomas Friesen
Kelly Lincoln Smith
Avinash Govind Thombre
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of GT200000222A publication Critical patent/GT200000222A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

UNA FORMA DE DOSIFICACION DE LIBERACION CONTROLADA TIENE UN NUCLEO RECUBIERTO, COMPRENDIENDO UNA COMPOSICION QUE CONTIENE A UN FARMACO Y UNA COMPOSICION HINCHABLE EN AGUA, OCUPANDO CADA UNA REGIONES SEPARADAS EN EL NUCLEO. LA COMPOSICION QUE CONTIENE EL FARMACO COMPRENDE UN FARMACO DE SOLUBILIDAD BAJA
GT200000222A 1999-12-23 2000-12-21 Forma de dosificacion de farmacos accionada por un hidrogel. GT200000222A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17196899P 1999-12-23 1999-12-23

Publications (1)

Publication Number Publication Date
GT200000222A true GT200000222A (es) 2002-06-14

Family

ID=22625827

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200000222A GT200000222A (es) 1999-12-23 2000-12-21 Forma de dosificacion de farmacos accionada por un hidrogel.

Country Status (42)

Country Link
US (3) US20020015731A1 (es)
EP (2) EP1967185A1 (es)
JP (1) JP4100910B2 (es)
KR (1) KR100523127B1 (es)
CN (1) CN1402632A (es)
AP (1) AP2002002553A0 (es)
AR (1) AR027091A1 (es)
AT (1) ATE392890T1 (es)
AU (1) AU783685B2 (es)
BG (1) BG106865A (es)
BR (1) BR0016708A (es)
CA (1) CA2395333C (es)
CR (1) CR6656A (es)
CZ (1) CZ20022046A3 (es)
DE (1) DE60038698T2 (es)
DK (1) DK1242055T3 (es)
DZ (1) DZ3228A1 (es)
EA (1) EA004370B1 (es)
EE (1) EE200200361A (es)
ES (1) ES2302705T3 (es)
GE (1) GEP20043334B (es)
GT (1) GT200000222A (es)
HU (1) HUP0301242A3 (es)
IL (1) IL149224A0 (es)
IS (1) IS6340A (es)
MA (1) MA26859A1 (es)
MX (1) MXPA02006328A (es)
NO (1) NO20022970D0 (es)
NZ (1) NZ518281A (es)
OA (1) OA12128A (es)
PA (1) PA8509001A1 (es)
PE (1) PE20010985A1 (es)
PL (1) PL357535A1 (es)
PT (1) PT1242055E (es)
SI (1) SI1242055T1 (es)
SK (1) SK8572002A3 (es)
SV (1) SV2002000250A (es)
TN (1) TNSN00253A1 (es)
TR (1) TR200201646T2 (es)
WO (1) WO2001047500A1 (es)
YU (1) YU35302A (es)
ZA (1) ZA200204960B (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY26615A1 (es) 2000-03-16 2001-10-25 Pfizer Prod Inc Inhibidor de la glucogeno fosforilasa.
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US20100196466A1 (en) * 2000-06-06 2010-08-05 Capricorn Pharma Inc. Drug delivery system
US7678387B2 (en) * 2000-06-06 2010-03-16 Capricorn Pharma, Inc. Drug delivery systems
US20070059367A1 (en) * 2000-06-06 2007-03-15 Cherukuri S R Drug Delivery System and Associated Methods
US7115279B2 (en) * 2000-08-03 2006-10-03 Curatolo William J Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
WO2003000226A2 (en) * 2001-06-22 2003-01-03 Pfizer Products Inc. Pharmaceutical compositions containing polymer and drug assemblies
WO2003004031A1 (en) 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic
ATE395044T1 (de) 2002-02-01 2008-05-15 Pfizer Prod Inc Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien
KR20040083493A (ko) * 2002-02-01 2004-10-02 화이자 프로덕츠 인크. 콜레스테릴 에스테르 전달 단백질 억제제의 제어 방출형제약상 제형
WO2003096968A2 (en) * 2002-05-15 2003-11-27 Sun Pharmaceutical Industries Limited Oral osmotic controlled drug delivery system
US20040076668A1 (en) * 2002-07-03 2004-04-22 Pfizer Inc. Controlled-release pharmaceutical formulations
WO2004050068A1 (en) 2002-11-29 2004-06-17 Janssen Pharmaceutica N.V. Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
EP1596837A2 (en) * 2003-02-07 2005-11-23 Omega Farma Ehf Sustained release formulations of venlafaxine
WO2004098572A1 (en) * 2003-05-06 2004-11-18 Ranbaxy Laboratories Limited Biphasic release of glipizide from monocompartment osmotic dosage form
ATE540671T1 (de) 2003-08-04 2012-01-15 Bend Res Inc Pharmazeutische zusammensetzungen von adsorbaten von amorphen arzneimitteln und lipophilen mikrophasen-bildenden materialien
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) * 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
CA2537413A1 (en) * 2003-09-02 2005-03-10 Imran Ahmed Sustained release dosage forms of ziprasidone
WO2006045152A1 (en) * 2004-10-29 2006-05-04 Mayne Pharma International Pty Ltd Improved tabletting process
WO2006072878A1 (en) * 2005-01-07 2006-07-13 Ranbaxy Laboratories Limited Oral dosage forms of sertraline having controlled particle size and processes for their preparation
GB0504547D0 (en) * 2005-03-04 2005-04-13 Delsol Products Ltd Personal lubricant
WO2006123364A2 (en) * 2005-03-14 2006-11-23 Sun Pharmaceutical Industries Limited Oral drug delivery system providing a coating comprising both a cellulose and a methacrylic acid derivative
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US7541347B2 (en) 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
WO2007057762A2 (en) * 2005-11-16 2007-05-24 Pfizer Limited Osmotic bi-layer tablet
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
CN101439026B (zh) * 2007-11-23 2011-04-06 北京红林制药有限公司 含有多沙唑嗪或其盐的控释制剂及其制备方法
MX2010008861A (es) * 2008-02-15 2011-02-22 Sun Pharma Advanced Res Co Ltd Tableta oral de liberacion controlada con efecto de liberacion masiva reducido.
WO2010017310A1 (en) 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
KR101004205B1 (ko) 2008-12-17 2010-12-24 동아제약주식회사 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물
KR101284368B1 (ko) 2010-07-09 2013-07-15 서울대학교산학협력단 나노섬유시트 기재의 경구용 약물의 제어 전달을 위한 시스템
WO2012103411A2 (en) * 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
US9918937B2 (en) * 2013-01-30 2018-03-20 Daewoong Co., Ltd. Pharmaceutical composition for protecting wounds, providing hemostasis, or preventing adhesion in the gastrointestinal tract
MX2015012416A (es) * 2013-03-14 2016-04-07 Amgen Inc Compuestos heterociclicos y sus usos.
CA2902646C (en) 2013-03-14 2022-08-16 Cytokinetics, Inc. Heterocyclic compounds and their uses
US20170182070A1 (en) 2014-10-08 2017-06-29 Mayne Pharma International Pty Ltd. Controlled Release Doxycycline
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
WO2017035408A1 (en) 2015-08-26 2017-03-02 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
RU2018145364A (ru) 2016-06-27 2020-07-28 Ачиллион Фармасьютикалс, Инк. Хиназолиновые и индольные соединения для лечения медицинских нарушений
EP3841086A4 (en) 2018-08-20 2022-07-27 Achillion Pharmaceuticals, Inc. PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MEDICAL DISORDERS RELATED TO COMPLEMENT FACTOR D
CN113365617A (zh) 2018-10-16 2021-09-07 乔治亚州立大学研究基金会股份有限公司 用于医学疾病治疗的一氧化碳前药
CN115768410A (zh) * 2020-07-10 2023-03-07 阿代尔制药股份有限公司 可溶胀的口服药物组合物
IL301389A (en) 2020-09-18 2023-05-01 Bristol Myers Squibb Co Dosage forms for TYK2 inhibitors that include swellable cores
TW202325285A (zh) * 2021-10-14 2023-07-01 靜岡縣公立大學法人 粉末製劑
WO2023154171A1 (en) * 2022-02-14 2023-08-17 Purdue Research Foundation Polymer salts for improved drug delivery from amorphous solid dispersions

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US5366738A (en) * 1982-07-29 1994-11-22 Merck & Co., Inc. Controlled release drug dispersion delivery device
IT1165797B (it) * 1982-10-18 1987-04-29 Consiglio Nazionale Ricerche Procedimento di preparazione di alchilangelicine esenti da psoraleni ed alchilangolicine ottenute col procedimento
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US5082668A (en) * 1983-05-11 1992-01-21 Alza Corporation Controlled-release system with constant pushing source
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
US4624848A (en) * 1984-05-10 1986-11-25 Ciba-Geigy Corporation Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
US4968507A (en) * 1984-06-20 1990-11-06 Merck & Co., Inc. Controlled porosity osmotic pump
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
US4865598A (en) * 1985-08-16 1989-09-12 Alza Corporation Dispensing system for administering beneficial agent
EP0277092B1 (de) * 1987-01-14 1992-01-29 Ciba-Geigy Ag Therapeutisches System für schwerlösliche Wirkstoffe
US4851232A (en) 1987-02-13 1989-07-25 Alza Corporation Drug delivery system with means for obtaining desirable in vivo release rate pattern
US4795641A (en) * 1987-08-20 1989-01-03 Eastman Kodak Company Polymer blends having reverse phase morphology for controlled delivery of bioactive agents
US5612059A (en) 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5096716A (en) * 1988-09-01 1992-03-17 Alza Corporation Dosage form for administering calcium antagonist nicardipine
US5034229A (en) * 1988-12-13 1991-07-23 Alza Corporation Dispenser for increasing feed conversion of hog
US5110596A (en) * 1988-12-13 1992-05-05 Alza Corporation Delivery system comprising means for delivering agent to livestock
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5186942A (en) * 1989-01-30 1993-02-16 Alza Corporation Nicardipine therapy
DD295760A5 (de) * 1989-01-31 1991-11-14 Martin-Luther-Universitaet Halle Wittenberg,De Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
US5019396A (en) * 1989-05-12 1991-05-28 Alza Corporation Delivery dispenser for treating cardiac arrhythmias
US5776493A (en) * 1989-07-14 1998-07-07 Alza Corporation Oral osmotic device for delivery of nystatin with hydrogel driving member
US5273752A (en) * 1989-07-18 1993-12-28 Alza Corporation Controlled release dispenser comprising beneficial agent
US5126142A (en) * 1989-07-18 1992-06-30 Alza Corporation Dispenser comprising ionophore
US5091190A (en) * 1989-09-05 1992-02-25 Alza Corporation Delivery system for administration blood-glucose lowering drug
US5035897A (en) * 1989-09-05 1991-07-30 Alza Corporation Dosage form for delivering soluble or insoluble drugs
US5120548A (en) * 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5200197A (en) * 1989-11-16 1993-04-06 Alza Corporation Contraceptive pill
US5151450A (en) * 1990-02-22 1992-09-29 Tokyo Tanabe Company, Limited Antiulcer substance
US5192550A (en) * 1990-05-07 1993-03-09 Alza Corporation Dosage form for treating central nervous system disorders
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5221536A (en) * 1990-05-07 1993-06-22 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5128145A (en) * 1990-06-13 1992-07-07 Alza Corporation Dosage form for Parkinson's disease, spasticity and muscle spasms
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
US5156850A (en) * 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
DK0550641T3 (da) * 1990-09-28 1994-08-22 Pfizer Dispenseringsanordning indeholdende et hydrofobt medium
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
PT100944B (pt) * 1991-10-10 2000-02-29 Alza Corp Dispositivo para o fornecimento osmotico de farmacos com paredes de materiais hidrofobicos
US5200195A (en) * 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
US5185158A (en) * 1992-02-27 1993-02-09 Alza Corporation Dosage form comprising succinimide drug for treating depressive disorders and composition comprising same
JP3140465B2 (ja) * 1992-09-18 2001-03-05 山之内製薬株式会社 ハイドロゲル徐放性製剤
US5358721A (en) * 1992-12-04 1994-10-25 Alza Corporation Antiviral therapy
EP0621032B1 (en) * 1993-04-23 2000-08-09 Novartis AG Controlled release drug delivery device
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
GB9326267D0 (en) * 1993-12-23 1994-02-23 Scherer Corp R P Expulsion of material
US5458887A (en) * 1994-03-02 1995-10-17 Andrx Pharmaceuticals, Inc. Controlled release tablet formulation
US5458888A (en) * 1994-03-02 1995-10-17 Andrx Pharmaceuticals, Inc. Controlled release tablet formulation
KR100232297B1 (ko) * 1994-05-06 1999-12-01 디. 제이. 우드 아지트로마이신의 제어된 방출 투여형 제제
US5698224A (en) * 1994-06-27 1997-12-16 Alza Corporation Tacrine therapy
US5529787A (en) * 1994-07-07 1996-06-25 Alza Corporation Hydromorphone therapy
US5582591A (en) * 1994-09-02 1996-12-10 Delab Delivery of solid drug compositions
US5718700A (en) * 1994-09-20 1998-02-17 Alza Corporation Exit means in dosage form
US5614578A (en) * 1994-10-28 1997-03-25 Alza Corporation Injection-molded dosage form
US5607696A (en) * 1995-02-10 1997-03-04 Alza Corporation Osmotic membrane and delivery device
US5736159A (en) * 1995-04-28 1998-04-07 Andrx Pharmaceuticals, Inc. Controlled release formulation for water insoluble drugs in which a passageway is formed in situ
US5817335A (en) * 1995-05-26 1998-10-06 Alza Corporation Osmotic device with high drug loading and delayed activation of drug delivery
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
FR2744733B1 (fr) * 1996-02-08 1998-04-24 Ascometal Sa Acier pour la fabrication de piece forgee et procede de fabrication d'une piece forgee
IT1290764B1 (it) * 1996-05-03 1998-12-10 Vevy Europ S P A Pentapeptide per la preparazione di composizioni dermo- farmaceutiche e cosmetiche per il trattamento di lesioni od affezioni cutanee
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US6271278B1 (en) * 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
EP0914098B1 (en) * 1997-05-30 2003-10-01 Osmotica Corp. Multi-layered osmotic device
ES2287971T3 (es) * 1997-08-11 2007-12-16 Pfizer Products Inc. Dispersiones farmaceuticas solidas con biodisponibilidad incrementada.
DE19737463A1 (de) * 1997-08-28 1999-03-04 Hoechst Marion Roussel De Gmbh Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden
US6037346A (en) * 1997-10-28 2000-03-14 Vivus, Inc. Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6706283B1 (en) 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
ATE433318T1 (de) * 1999-02-10 2009-06-15 Pfizer Prod Inc Osmotisches system zur verabreichung von wirkstoffen, die feste amorphe dispersionen enthalten
US6245200B1 (en) 1999-12-10 2001-06-12 Sandia Corporation Photo-oxidation method using MoS2 nanocluster materials
WO2001047498A2 (en) * 1999-12-23 2001-07-05 Pfizer Products Inc. Hydrogel-driven layered drug dosage form comprising sertraline
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form

Also Published As

Publication number Publication date
TNSN00253A1 (fr) 2002-05-30
EP1242055A1 (en) 2002-09-25
JP4100910B2 (ja) 2008-06-11
BG106865A (bg) 2003-03-31
CA2395333C (en) 2009-01-13
CA2395333A1 (en) 2001-07-05
OA12128A (en) 2006-05-05
TR200201646T2 (tr) 2002-11-21
CR6656A (es) 2004-04-29
CZ20022046A3 (cs) 2002-11-13
ATE392890T1 (de) 2008-05-15
HUP0301242A2 (hu) 2004-05-28
KR100523127B1 (ko) 2005-10-20
SK8572002A3 (en) 2002-12-03
ES2302705T3 (es) 2008-08-01
MA26859A1 (fr) 2004-12-20
EA004370B1 (ru) 2004-04-29
DZ3228A1 (fr) 2001-07-05
EE200200361A (et) 2003-10-15
AU783685B2 (en) 2005-11-24
US9028870B2 (en) 2015-05-12
EP1967185A1 (en) 2008-09-10
JP2003518489A (ja) 2003-06-10
CN1402632A (zh) 2003-03-12
KR20020070330A (ko) 2002-09-05
NO20022970L (no) 2002-06-20
PL357535A1 (en) 2004-07-26
SV2002000250A (es) 2002-02-05
DE60038698D1 (de) 2008-06-05
BR0016708A (pt) 2002-10-08
US20020015731A1 (en) 2002-02-07
US20110182947A1 (en) 2011-07-28
IS6340A (is) 2002-04-12
GEP20043334B (en) 2004-03-10
NO20022970D0 (no) 2002-06-20
AP2002002553A0 (en) 2002-06-30
YU35302A (sh) 2005-03-15
AR027091A1 (es) 2003-03-12
PA8509001A1 (es) 2002-02-21
AU2018901A (en) 2001-07-09
EA200200595A1 (ru) 2002-12-26
IL149224A0 (en) 2002-11-10
SI1242055T1 (sl) 2008-08-31
WO2001047500A1 (en) 2001-07-05
PE20010985A1 (es) 2001-09-28
ZA200204960B (en) 2003-10-02
NZ518281A (en) 2005-01-28
PT1242055E (pt) 2008-07-02
EP1242055B1 (en) 2008-04-23
HUP0301242A3 (en) 2006-07-28
US20070087057A1 (en) 2007-04-19
MXPA02006328A (es) 2002-12-13
DK1242055T3 (da) 2008-07-21
DE60038698T2 (de) 2009-05-07

Similar Documents

Publication Publication Date Title
GT200000222A (es) Forma de dosificacion de farmacos accionada por un hidrogel.
ECSP034455A (es) Forma de dosificacion de farmaco activada por hidrogel
ES2185816T3 (es) Formas de dosificacion farmaceutica para la via oral, que comprenden un agente inhibidor de la bomba de protones y un agente procinetico.
AR065809A1 (es) Formulaciones farmaceuticas que contienen un inhibidor sglt2
IS6150A (is) Næringar- eða lyfjasamsetningar til nota við fyrirbyggingu eða meðhöndlun á ofurkalsíum oxalat myndun
PA8578301A1 (es) Composicion de tabletas de liberacion sostenida de pramipexol
PA8484301A1 (es) Formulaciones farmaceuticas de liberacion controlada
NO992102D0 (no) Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
CY2347B1 (en) Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route.
DZ3155A1 (fr) Nouvelle composition pharmaceutique.
AR028448A1 (es) Formulaciones que contienen una droga glucocorticoide para el tratamiento de enfermedades broncopulmonares
PA8523101A1 (es) Composicion de eletriptan en forma de particulas
ES2180729T3 (es) Tratamiento terapeutico combinado de las patologias hiperproliferantes.
DZ3164A1 (fr) Nouvel agent pharmaceutique.
AR024959A1 (es) Una composicion farmaceutica liquida basada en paracetamol
GT200300017A (es) Sistema de suministro osmotico
SV2006002223A (es) Composicion farmaceutica ref. bhco41369-sv
ES2033169B1 (es) Recipiente para el cultivo de algas y procedimiento para su utilizacion.
AR030660A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso de la produccion de il-12
CU23203A1 (es) Formulaciones que contienen agentes de accion trombolitica para su administracion por via rectal
MC200066A1 (fr) Forme posologique pharmaceutique portant une signalétique indiquant une parfaite innocuité en cas degrossesse
PE20020055A1 (es) Formulaciones estables liquidas y solidas que comprenden una antihistamina no sedante y un descongestionante nasal
ITRM20020357A0 (it) Composizione liquida per la somministrazione orale di lorazepam.
ES2187440T3 (es) Utilizacion de orosomucoide en un preparado farmaceutico para el tratamiento de pancreatitis aguda.
ECSP003856A (es) Forma de dosificacion de farmaco en capas impulsada por hidrogel